Page last updated: 2024-08-24

tangeretin and Dyslipidemias

tangeretin has been researched along with Dyslipidemias in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chao, TY; Chen, PY; Gao, WY; Hsu, HJ; Lin, CY; Wang, CY; Wu, MJ; Yen, JH	1

Other Studies

1 other study(ies) available for tangeretin and Dyslipidemias

Article	Year
The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells. International journal of molecular sciences, 2021, Sep-12, Volume: 22, Issue:18 Topics: Angiopoietin-Like Protein 3; Angiopoietin-like Proteins; Drug Evaluation, Preclinical; Dyslipidemias; Flavones; Hep G2 Cells; Humans; Lipase; Lipid Metabolism; Liver X Receptors	2021

Article

Year

The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells.

International journal of molecular sciences, 2021, Sep-12, Volume: 22, Issue:18

Topics: Angiopoietin-Like Protein 3; Angiopoietin-like Proteins; Drug Evaluation, Preclinical; Dyslipidemias; Flavones; Hep G2 Cells; Humans; Lipase; Lipid Metabolism; Liver X Receptors

2021